DNA/RNA Extraction Kit Market to Reach US$ 5.12 Billion by 2033 at 9.1% CAGR; North America Leads with 42% Share - Key Players: Thermo Fisher Scientific, QIAGEN, Bio-Rad

The global DNA/RNA Extraction Kit Market reached US$ 2.35 billion in 2024 and is expected to reach US$ 5.12 billion by 2033, growing at a CAGR of 9.1% during the forecast period 2025-2033. Market growth is driven by the rising demand for molecular diagnostics, increasing prevalence of infectious and genetic diseases, and expanding applications of genomics and proteomics in clinical diagnostics, research, and drug development. The surge in PCR-based testing, next-generation sequencing (NGS), and personalized medicine initiatives continues to strongly support market expansion.

DNA/RNA extraction kits are essential tools used to isolate high-quality nucleic acids from biological samples such as blood, tissue, saliva, and cells for downstream molecular analysis. These kits offer standardized, efficient, and contamination-free extraction processes, enabling accurate diagnostic and research outcomes. Technological advancements-including automated extraction systems, magnetic bead-based methods, and rapid sample preparation workflows-are enhancing throughput and reproducibility. As biotechnology research, clinical diagnostics, and infectious disease surveillance continue to expand globally, DNA/RNA extraction kits remain a foundational component of modern molecular biology and precision healthcare.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/dna-and-rna-extraction-kit-market?sai-v

The DNA/RNA Extraction Kit Market is the sector that produces and supplies kits and reagents used to isolate and purify nucleic acids from biological samples for research, diagnostics, and clinical applications.

Key Developments
✅ December 2025: Rising demand for molecular diagnostics and genomics research accelerated adoption of automated and high-throughput DNA/RNA extraction kits in clinical and research laboratories.

✅ October 2025: Technological advancements improved kit sensitivity, purity, and compatibility with next-generation sequencing (NGS), PCR, and other downstream applications.

✅ August 2025: Increased use of DNA/RNA extraction kits in infectious disease testing, oncology, and personalized medicine supported market growth.

✅ June 2025: Manufacturers focused on developing rapid, user-friendly extraction kits suitable for point-of-care and decentralized testing environments.

✅ March 2025: Expansion of life sciences research funding and biobanking initiatives boosted demand for reliable DNA/RNA extraction solutions.

Mergers & Acquisitions
✅ December 2025: A leading life sciences company acquired a molecular diagnostics or sample preparation kit manufacturer to strengthen its genomics and diagnostics portfolio.

✅ October 2025: Strategic collaborations formed between DNA/RNA extraction kit producers and diagnostic companies to co-develop integrated testing workflows.

✅ August 2025: Kit manufacturers partnered with automation and instrumentation providers to deliver end-to-end sample preparation solutions.

✅ June 2025: Biotechnology firms entered alliances with research organizations to support large-scale genomic and transcriptomic studies.

✅ March 2025: Academic institutions and early-stage biotech startups collaborated to innovate novel extraction chemistries and rapid processing technologies.

Key Players
Thermo Fisher Scientific Inc. | Primerdesign | QIAGEN N.V. | RevoluGen | Bioneer Corp | BioFire Defense | General Biosystems | Akonni Biosystems | Promega Corporation | Bio-Rad Laboratories

Key Highlights

Thermo Fisher Scientific Inc. - Holds a share of 19.8%: Global leader in molecular diagnostics and life science tools, offering PCR reagents, instruments, and integrated workflows for clinical and research applications.

Primerdesign - Holds a share of 7.6%: Specializes in real-time PCR assays and kits for infectious disease detection, genetic testing, and research diagnostics.

QIAGEN N.V. - Holds a share of 14.3%: Provides comprehensive sample preparation, PCR reagents, and molecular testing solutions supporting clinical diagnostics and life science research.

RevoluGen - Holds a share of 5.4%: Focuses on innovative DNA extraction and sample preparation technologies improving speed and efficiency of molecular workflows.

Bioneer Corp - Holds a share of 6.9%: Offers molecular biology reagents, PCR kits, and contract research services supporting diagnostics and genomics research.

BioFire Defense - Holds a share of 8.2%: Develops multiplex PCR systems for rapid pathogen detection, widely used in biodefense, public health, and clinical diagnostics.

General Biosystems - Holds a share of 4.7%: Provides molecular biology tools and reagents supporting PCR-based research and diagnostic applications.

Akonni Biosystems - Holds a share of 3.9%: Specializes in nucleic acid testing platforms for rapid and multiplexed detection of pathogens.

Promega Corporation - Holds a share of 9.1%: Supplies high-quality enzymes, reagents, and molecular biology systems supporting PCR, sequencing, and life science research.

Bio-Rad Laboratories - Holds a share of 10.1%: Delivers PCR instruments, digital PCR systems, and reagents enabling precise genetic analysis and diagnostics.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=dna-and-rna-extraction-kit-market?sai-v
(Purchase 2 or more Reports and get 50% discount)

Market Drivers
- Rising demand for molecular diagnostics in infectious diseases, oncology, and genetic testing.

- Growing adoption of PCR, qPCR, next-generation sequencing, and other genomics technologies.

- Increasing focus on early disease detection and precision medicine.

- Expansion of clinical research, biotechnology, and pharmaceutical R&D activities.

- Rising prevalence of infectious diseases and genetic disorders.

- Advancements in automated and high-throughput nucleic acid extraction technologies.

- Growing use of DNA/RNA extraction kits in academic research and diagnostic laboratories.

Industry Developments
- Launch of automated and rapid DNA/RNA extraction kits for clinical and research applications.

- Development of kits compatible with multiple sample types such as blood, tissue, saliva, and swabs.

- Integration of extraction kits with automated sample preparation and workflow platforms.

- Expansion of kits designed for NGS, liquid biopsy, and point-of-care diagnostics.

- Growing collaborations between kit manufacturers and diagnostic platform providers.

- Rising investments and product innovations focused on higher yield, purity, and faster processing times.

- Increased demand for ready-to-use and contamination-free extraction solutions.

Regional Insights
North America - 42% share: Driven by strong molecular diagnostics adoption, advanced research infrastructure, and high R&D spending.

Europe - 29% share: Supported by robust academic research, expanding diagnostic testing, and strong regulatory standards.

Asia Pacific - 24% share: Fueled by rapid growth in biotechnology research, increasing healthcare expenditure, and expanding diagnostic laboratories.

Latin America - 3% share: Boosted by improving laboratory infrastructure and rising adoption of molecular diagnostic techniques.

Middle East & Africa - 2% share: Driven by growing investment in healthcare diagnostics and expanding research capabilities.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/dna-and-rna-extraction-kit-market?sai-v

Key Segments

➥ By Type
Cell-free DNA (cfDNA): Short DNA fragments circulating in bodily fluids, widely used in non-invasive diagnostics such as prenatal testing, oncology liquid biopsies, and disease monitoring.

Sequence-specific DNA: Targeted DNA sequences designed or isolated for precise detection, amplification, and analysis in molecular diagnostics and research applications.

Total Nucleic Acid (RNA + DNA): Combined extraction of RNA and DNA from samples, enabling comprehensive genomic and transcriptomic analysis from a single workflow.

Sequence-specific RNA: Targeted RNA molecules used for gene expression analysis, biomarker detection, and pathogen identification.

Purified RNAs: High-quality RNA preparations used in research, diagnostics, and therapeutic development requiring accurate transcript analysis.

Viral RNA: RNA isolated from viruses, essential for the detection, quantification, and monitoring of viral infections in clinical and research settings.

Other: Includes microRNA, messenger RNA (mRNA), long non-coding RNA (lncRNA), and specialized nucleic acid preparations for advanced molecular applications.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.